ABclonal Technology, a provider of reagents used in life science research, has raked in 1.2 billion yuan ($189 million) in a Series D round of financing, the investee announced on Wednesday. The fresh …
( read original story …)
The Shanghai News
ABclonal Technology, a provider of reagents used in life science research, has raked in 1.2 billion yuan ($189 million) in a Series D round of financing, the investee announced on Wednesday. The fresh …
( read original story …)